Completed NA INTERVENTIONAL NCT00087659

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

Sponsor: Novartis Pharmaceuticals

Updated 6 times since 2017 Last updated: Nov 20, 2009 Started: Dec 31, 2003 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00087659, this NA trial focuses on Prostate Cancer and remains completed. Sponsored by Novartis Pharmaceuticals, it has been updated 6 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis Pharmaceuticals

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augusta, United States , Buffalo, United States , Chicago, United States , Columbia, United States , Decatur, United States , Detroit, United States , East Orange, United States , Hines, United States , Kansas City, United States , Long Beach, United States and 6 more locations